Rehabilitation Therapy in Peripheral Arterial Disease

被引:16
作者
Aggarwal, Sandeep [1 ,2 ]
Moore, Randy D. [3 ]
Arena, Ross [4 ,5 ]
Marra, Brenda [2 ]
McBride, Amanda [2 ]
Lamb, Brea [2 ]
Martin, Billie-Jean [6 ]
Stone, James [1 ,2 ]
机构
[1] Univ Calgary, Calgary, AB, Canada
[2] TotalCardiol Rehabil & Risk Reduct, Calgary, AB, Canada
[3] Univ Calgary, Dept Surg, Calgary, AB, Canada
[4] Univ Illinois, Dept Phys Therapy, Dept Kinesiol & Nutr, Chicago, IL USA
[5] Univ Illinois, Integrat Physiol Lab, Coll Appl Hlth Sci, Chicago, IL USA
[6] Univ Alberta, Dept Surg, Edmonton, AB, Canada
关键词
ANKLE-BRACHIAL INDEX; SUPERVISED EXERCISE; INTERMITTENT CLAUDICATION; FUNCTIONAL PERFORMANCE; COST-EFFECTIVENESS; RISK-FACTORS; MORTALITY; REVASCULARIZATION; PREVENTION; PROGRAM;
D O I
10.1016/j.cjca.2016.07.509
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Peripheral arterial disease (PAD) is the result of atherosclerosis in the lower limb arteries, which can give rise to intermittent claudication (IC), limb ulceration, infections, and, in some circumstances, amputation. As a result of PAD, patients are frequently limited in both walking duration and speed. These ambulatory deficits impact both functional capacity and quality of life. The prevalence of PAD is increasing, and patients with this diagnosis have high cardiovascular morbidity and mortality. A comprehensive approach is required to improve outcomes in patients with PAD and include tobacco cessation, pharmacologic management of metabolic fitness, risk-factor modification, and exercise training. Supervised exercise programs significantly improve functional capacity and quality of life in addition to reducing IC. These programs reduce morbidity and mortality and are cost-effective; yet they are uncommonly prescribed. Supervised exercise training is an accepted intervention in the PAD population and has been included in both Canadian and American guidelines for PAD management. This review describes (1) key background information related to PAD, (2) the initial approach to PAD diagnosis, (3) pharmacologic management options, (4) risk-factor modification, and (5) the currently accepted approach to exercise training. Key recommendations for enhancing PAD care in a Canadian context are also discussed.
引用
收藏
页码:S374 / S381
页数:8
相关论文
共 58 条
[1]  
Abramson BL, 2005, CAN J CARDIOL, V21, P997
[2]   Association of dual-antiplatelet therapy with reduced major adverse cardiovascular events in patients with symptomatic peripheral arterial disease [J].
Armstrong, Ehrin J. ;
Anderson, David R. ;
Yeo, Khung-Keong ;
Singh, Gagan D. ;
Bang, Heejung ;
Amsterdam, Ezra A. ;
Freischlag, Julie A. ;
Laird, John R. .
JOURNAL OF VASCULAR SURGERY, 2015, 62 (01) :156-165
[3]  
Badger Stephen A, 2007, Vasc Endovascular Surg, V41, P27, DOI 10.1177/1538574406296209
[4]   Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial [J].
Belch, Jill J. F. ;
Dormandy, John .
JOURNAL OF VASCULAR SURGERY, 2010, 52 (04) :825-833
[5]   Aspirin for the Prevention of Cardiovascular Events in Patients With Peripheral Artery Disease A Meta-analysis of Randomized Trials [J].
Berger, Jeffrey S. ;
Krantz, Mori J. ;
Kittelson, John M. ;
Hiatt, William R. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 301 (18) :1909-1919
[6]   The Cost-effectiveness of Supervised Exercise for the Treatment of Intermittent Claudication [J].
Bermingham, S. L. ;
Sparrow, K. ;
Mullis, R. ;
Fox, M. ;
Shearman, C. ;
Bradbury, A. ;
Michaels, J. .
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2013, 46 (06) :707-714
[7]   Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events [J].
Bhatt, DL ;
Fox, KAA ;
Hacke, W ;
Berger, PB ;
Black, HR ;
Boden, WE ;
Cacoub, P ;
Cohen, EA ;
Creager, MA ;
Easton, JD ;
Flather, MD ;
Haffner, SM ;
Hamm, CW ;
Hankey, GJ ;
Johnston, SC ;
Mak, KH ;
Mas, JL ;
Montalescot, G ;
Pearson, TA ;
Steg, PG ;
Steinhubl, SR ;
Weber, MA ;
Brennan, DM ;
Fabry-Ribaudo, L ;
Booth, J ;
Topol, EJ ;
Frye, RL ;
Amarenco, P ;
Brass, LM ;
Buyse, M ;
Cohen, LS ;
DeMets, DL ;
Fuster, V ;
Hart, RG ;
Marler, JR ;
McCarthy, C ;
Schoemig, A ;
Lincoff, AM ;
Brener, SJ ;
Sila, CA ;
Albuquerque, A ;
Aroutiounov, G ;
Artemiev, D ;
Atkeson, BG ;
Bartel, T ;
Basart, DCG ;
Lima, AB ;
Belli, G ;
Bordalo e Sa, AL ;
Bosch, X .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (16) :1706-1717
[8]   Twelve-Months Follow-up of Supervised Exercise after Percutaneous Transluminal Angioplasty for Intermittent Claudication: A Randomised Clinical Trial [J].
Bo, Elisabeth ;
Hisdal, Jonny ;
Cvancarova, Milada ;
Stranden, Einar ;
Jorgensen, Jorgen J. ;
Sandbaek, Gunnar ;
Grotta, Ole J. ;
Bergland, Astrid .
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2013, 10 (11) :5998-6014
[9]   Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease [J].
Bonaca, Marc P. ;
Bhatt, Deepak L. ;
Storey, Robert F. ;
Steg, Gabriel ;
Cohen, Marc ;
Kuder, Julia ;
Goodrich, Erica ;
Nicolau, Jose C. ;
Parkhomenko, Alexander ;
Lopez-Sendon, Jose ;
Dellborg, Mikael ;
Dalby, Anthony ;
Spinar, Jindrich ;
Aylward, Philip ;
Corbalan, Ramon ;
Abola, Maria Teresa B. ;
Jensen, Eva C. ;
Held, Peter ;
Braunwald, Eugene ;
Sabatine, Marc S. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (23) :2719-2728
[10]   Pharmacist influence on prescribing in peripheral arterial disease (PIPER) [J].
Brook-Barclay, Laura ;
Delaney, Christopher L. ;
Scicchitano, Madeleine ;
Quinn, Stephen ;
Spark, James I. .
VASCULAR MEDICINE, 2014, 19 (02) :118-124